Free Access
| Issue |
Med Sci (Paris)
Volume 32, Number 11, Novembre 2016
Le microbiote : cet inconnu qui réside en nous
|
|
|---|---|---|
| Page(s) | 1035 - 1037 | |
| Section | Forum | |
| DOI | https://doi.org/10.1051/medsci/20163211024 | |
| Published online | 23 December 2016 | |
- Jordan B. CRISPR-Cas9, une nouvelle donne pour la thérapie génique. Med Sci (Paris) 2015 ; 31 : 1035–1038. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Fesnak AD, June CH, Levine BL Engineered T cells: the promise and challenges of cancer immunotherapy. Nat Rev Cancer 2016 ; 16 : 566–581. [CrossRef] [PubMed] [Google Scholar]
- Rapoport AP, Stadtmauer EA, Binder-Scholl GK, et al. NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma. Nat Med 2015 ; 21 : 914–921. [CrossRef] [PubMed] [Google Scholar]
- Kreamer KM Immune checkpoint blockade: a new paradigm in treating advanced cancer. J Adv Pract Oncol 2014 ; 5 : 418–431. [PubMed] [Google Scholar]
- Schumann K, Lin S, Boyer E, et al. Generation of knock-in primary human T cells using Cas9 ribonucleoproteins. Proc Natl Acad Sci USA 2015 ; 112 : 10437–10442. [CrossRef] [Google Scholar]
- Su S, Hu B Shao J CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients. Sci Rep 2016 ; 6 : 20070. [CrossRef] [PubMed] [Google Scholar]
- https://fr.scribd.com/doc/316280454/RAC-Review-Penn-Medicine-CRISPR-NYESO-1-Immunetherapy-study (Accessed 28/8/2016). [Google Scholar]
- Cyranoski D. Chinese scientists to pioneer first human CRISPR trial. Nature 2016 ; 535 : 476–477. [CrossRef] [PubMed] [Google Scholar]
- https://clinicaltrials.gov/ct2/show/NCT02793856 (accessed 28/8/2016). [Google Scholar]
- Champiat S, Lambotte O, Barreau E, et al. Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper. Ann Oncol 2016 ; 27 : 559–574. [CrossRef] [PubMed] [Google Scholar]
- Niu Y, Shen B, Cui Y, et al. Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos. Cell 2014 ; 156 : 836–843. [CrossRef] [PubMed] [Google Scholar]
- Liang P, Xu Y, Zhang X, et al. CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes. Protein Cell 2015 ; 6 : 363–372. [CrossRef] [PubMed] [Google Scholar]
- Peng Y. The morality and ethics governing CRISPR-Cas9 patents in China. Nat Biotechnol 2016 ; 34 : 616–618. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.